Participants:18–64 years · 65+ years
Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Septic shock

Not recruiting

Registered drugNo placebo

Study on Resuscitation in Early Septic Shock Using Sodium Chloride and a Drug Combination for Patients with Septic Shock

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Potassium Chloride

Contact Research Centre

Multiple sclerosis

Not recruiting

Investigational

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational

Spain

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Thrombotic thrombocytopenic purpura

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Apadamtase Alfa

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Find therapies in clinical trials near you – page 11

201 trials match your criteria

Chronic kidney disease+1

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Small cell lung cancer

Study of Durvalumab for Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

COVID-19

Study on the Safety and Immune Response of PHH-1V81 Booster for Adults Vaccinated Against COVID-19

Hormone-refractory prostate cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Parkinson's disease

Study of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients

Asthma

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Septic shock

Study on Resuscitation in Early Septic Shock Using Sodium Chloride and a Drug Combination for Patients with Septic Shock

Multiple sclerosis

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Breast cancer+1

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Thrombotic thrombocytopenic purpura

Study on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Parkinson's disease

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Multiple sclerosis relapse

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.